At the IGTP TODAY
The research is part of the European project HYPIEND, coordinated by the Eurecat technology centre, and with the participation of IGTP-HUGTiP.
To mark World Water Day, researcher Noemí Párraga focuses on Legionella. Despite advances in detection and prevention, case numbers continue to rise, highlighting the need to strengthen control measures in high-risk facilities.
Researchers at IGTP have led a study that evaluates, for the first time, the difference between sexes in advanced liver disease in a rat model. The study has been published in the journal Laboratory Animals and has been conducted at the facilities of the CMCiB.
The SMA-TB project, an initiative coordinated by the Experimental Tuberculosis Unit (UTE) at IGTP and funded by the European Commission's H2020 programme, has reached its conclusion after five years of research aimed at improving tuberculosis treatments.
According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID.
Specialists from the Digestive System Department at the Hospital Germans Trias and the Inflammatory Bowel Disease Research Group (GReMII) at IGTP have led and published a unique study that represents an improvement in the monitoring and treatment of patients who have undergone surgery due to one of the main inflammatory bowel diseases: Crohn's disease.
Researchers from IDIBELL and IGTP have studied variations in mRNA length during the progression of atherosclerosis in a mouse model. The results could help identify new biomarkers and potential therapeutic targets.
A new study has examined the complex personal factors influencing breastfeeding decisions among young breast cancer survivors. The authors emphasise the importance of specialised and personalised professional support for these patients.
A team led by the Cancer Immunogenomics group at IJC, BSC and IGTP shows, for the first time, that within a tumour, the expression of the different hallmarks of cancer is not cell-specific, but rather position-specific. Under this new light, tumour architecture emerges as a valuable source of information to understand tumour dynamics and predict its sensitivity to anticancer drugs.
IGTP has been awarded €3,547,417 in funding to conduct the "DM1-Hub" project, coordinated by Dr Gisela Nogales Gadea, leader of GRENBA, with Dr. Arturo López Castel of INCLIVA serving as co-principal investigator.
